A Phase I, Prospective, Randomized, Open-labeled Study to Evaluate the Safety, Tolerability, and Immunogenicity of Booster Dose with MVC-COV1901 or MVC-COV1901(Beta) SARS-CoV-2 Vaccine in Adults

Chia En Lien, Ming-Che Liu, Ning-Chi Wang, Luke Tzu-Chi Liu, Chung-Chin Wu, Wei-Hsuan Tang, Wei-Cheng Lian, Kuan-Ying A. Huang, Charles Chen
doi: https://doi.org/10.1101/2022.08.29.22279317
Back to top
Posted August 31, 2022.
Download PDF

Supplementary Material

Data/Code
Email
A Phase I, Prospective, Randomized, Open-labeled Study to Evaluate the Safety, Tolerability, and Immunogenicity of Booster Dose with MVC-COV1901 or MVC-COV1901(Beta) SARS-CoV-2 Vaccine in Adults
Chia En Lien, Ming-Che Liu, Ning-Chi Wang, Luke Tzu-Chi Liu, Chung-Chin Wu, Wei-Hsuan Tang, Wei-Cheng Lian, Kuan-Ying A. Huang, Charles Chen
medRxiv 2022.08.29.22279317; doi: https://doi.org/10.1101/2022.08.29.22279317
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area